Loading...
OTCM
IGNE
Market cap15kUSD
May 27, Last price  
0.00USD
Name

Igene Biotechnology Inc

Chart & Performance

D1W1MN
No data to show
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
20.03%
Revenues
4m
-48.23%
18,131702,5334,181,0373,491,765463,48602,286,7307,644,4773,957,903
Net income
-141k
L-96.47%
-2,525,340-2,255,315-3,672,959-3,189,980-2,199,141-1,155,773-1,899,073-3,990,937-140,747
CFO
-97k
L
-1,670,094-1,813,746-2,139,517-1,312,880-173,6161001,310,465705,610-97,049

Profile

Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors; and analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.
IPO date
Jul 29, 1986
Employees
18
Domiciled in
US
Incorporated in
US

Valuation

No data to show